home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Alterity Therapeutics Limited - American Depositary Shares (NQ:ATHE)

3.430 -0.090 (-2.56%)

Streaming Delayed Price Updated: 3:59 PM EST, Mar 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Alterity Therapeutics Limited - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 Next >

Alterity Therapeutics Enrolls First Patient in Australia in ATH434 Global Phase 2 Clinical Trial in Multiple System Atrophy

May 10, 2023

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Alterity Therapeutics Presents Promising Wearable Sensor Data from the bioMUSE Natural History Study at the American Academy of Neurology

April 26, 2023

Wearable sensor parameters correlate strongly with clinical scales of motor impairment

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Alterity Therapeutics Enrolls First Patient in the United Kingdom in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy

April 04, 2023

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Alterity Therapeutics Enrolls First Patient in the U.S. in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy

March 16, 2023

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Why PacWest Bancorp Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket ↗

March 14, 2023

Gainers PacWest Bancorp (NASDAQ: PACW) rose 29.9% to $12.66 in pre-market trading after multiple insider buys by Officers, Directors reported late Monday.

Via Benzinga

Alterity Therapeutics Announces Granting of New Composition of Matter Patent and Exclusive License Agreement for Assets in Alzheimer’s Disease

March 14, 2023

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Alterity Therapeutics Enrolls First Patient in Italy in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy

March 08, 2023

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Alterity Therapeutics Receives Regulatory Authorization in France and Austria to Proceed with ATH434 Phase 2 Clinical Trial

February 16, 2023

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Alterity's Parkinson's Candidate Prevents Loss Of Brain Cells In Animal Model ↗

January 30, 2023

Via Benzinga

Here's Why Alterity Therapeutics Shares Are Moving ↗

January 30, 2023

Alterity Therapeutics Ltd (NASDAQ: ATHE) shares are trading higher by 5.67% to $4.12 Monday morning after the company announced ATH434 prevents loss of brain cells in Parkinson's Disease animal model.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 30, 2023

Via Benzinga

5 Most Expensive Health Care Stocks You Should Worry About ↗

January 12, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

December 13, 2022

On Tuesday, 49 companies hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 02, 2022

Via Benzinga

Why DraftKings Shares Are Trading Lower By 5%; Here Are 24 Stocks Moving Premarket ↗

November 28, 2022

Gainers Talkspace, Inc. (NASDAQ: TALK) shares rose 48.3% to $0.89 in pre-market trading. Talkspace recently named Jon Cohen as CEO.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

November 28, 2022

Welcome back, trader! It's time to check out the biggest pre-market stock movers that traders will want to know about on Monday!

Via InvestorPlace

Stocks That Hit 52-Week Lows On Tuesday ↗

October 25, 2022

On Tuesday, 120 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 20, 2022

Gainers Nuwellis (NASDAQ:NUWE) stock rose 13.9% to $0.28 during Thursday's after-market session. The company's market cap stands at $8.9 million.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 22, 2022

Gainers Spero Therapeutics (NASDAQ:SPRO) shares moved upwards by 122.7% to $1.83 during Thursday's pre-market session. The market value of their outstanding shares is at $64.1 million.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

September 22, 2022

It's time for an overview of the biggest pre-market stock movers for Thursday and all the news behind this morning's movement.

Via InvestorPlace

Here's Why Alterity Therapeutics Shares Are Volatile ↗

September 20, 2022

Alterity Therapeutics Ltd (NASDAQ: ATHE) shares are trading sharply lower by 14.29% to $0.48, reversing following earlier strength, after the company announced the approval of its Investigational New...

Via Benzinga

Why O2Micro International Is Trading Higher By 7%; Here Are 25 Stocks Moving Premarket ↗

September 20, 2022

Gainers

Via Benzinga

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary ↗

August 25, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2022 ↗

August 03, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

July 21, 2022

During Thursday's trading, 50 companies set new 52-week lows.

Via Benzinga

Alterity Commences Mid-Stage Neurodegenerative Disorder Study ↗

July 06, 2022

Alterity Therapeutics (NASDAQ: ATHE) doses first subject in its Phase 2 clinical trial of lead candidate ATH434 in Multiple System Atrophy (MSA), a rare and highly debilitating Parkinsonian disorder.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 11, 2022

Gainers Dermata Therapeutics (NASDAQ:DRMA) stock rose 29.0% to $1.38 during Friday's pre-market session. The company's market cap stands at $11.4 million. Innoviva...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 10, 2022

Gainers Dermata Therapeutics (NASDAQ:DRMA) stock moved upwards by 27.1% to $1.36 during Thursday's pre-market session. The company's market cap stands at $11.3...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 08, 2022

Gainers Second Sight Medical (NASDAQ:EYES) stock increased by 7.8% to $1.51 during Tuesday's pre-market session. The market value of their outstanding shares is at $59...

Via Benzinga

21 Stocks Moving in Tuesday's Pre-Market Session ↗

February 08, 2022

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep. Also check out this: Moderna And 4 Other Stocks Sold By...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com